Turkish Adaptation of ACTIVLIM Questionnaire in Neuromuscular Diseases by Rasch Analysiz

Yıl 2019, Cilt: 7 Sayı: 3, 135 - 144, 05.09.2019

Muhammed Kılınç , Çiğdem Öksüz , Derya Gökmen İpek Gürbüz Cevher Demirci , Hatice Abaoğlu , Sibel Aksu Yıldırım , Öznur Tunca Yılmaz

https://doi.org/10.30720/ered.545187

Cited By: 1

Öz

Purpose: The aim of this study was to
assess the reliability and validity of the ACTIVLIM questionnaire for
Turkish-speaking neuromuscular disease (NMD) patients with the Rasch analysis.

Methods: 169 NMD patients were included
to the study. The independence level regarding activities of daily living was
assessed using the Functional Independence Measurement (FIM) scale while
activity limitation was evaluated with the Activlim questionnaire. All
assessments were performed twice, at the beginning of the study and 15 days
later. Statistically analysis were done by using Rasch method.

Results:  95 children with a median age of 10 and 74
adults with a median age of 34.5 years were included to the study. Seventy
patients (41.7%) were assessed a second time. Starting with 22 items, one item
(ACTIVLIM 5- Sitting on the toilet) displayed disordered thresholds,
necessitating collapsing of categories. According to test/retest reliability, none
of the items showed differential item functioning.  Internal consistency of the scale is
sufficent (Cronbach’s alpha  0.94). The
scale showed expected correlation with FIM scores ( Pearson 0.95) which  revealed external construct validityof the
scale.

Conclusion: ACTIVLIM is found as a
reliable and valid questionnaire that can be used in the Turkish NMD population
to assess activity limitation.

Anahtar Kelimeler

Neuromuscular Disease, Reliability and Validity, Activities of Daily Living

ACTIVLIM Ölçeği’nin RASCH Analizi ile Nöromusküler Hastalıklarda Türkçe Adaptasyonu

Öz

Amaç: Bu çalışmanın amacı, Türkçe
konuşan nöromüsküler hastalığı (NMH) olan bireylerde ACTIVLIM Ölçeği’nin Rasch
analizi ile güvenirlik ve geçerliğini değerlendirmektir.

Yöntem: Çalışmaya 169 NMH hastası dahil
edildi. Günlük yaşam aktiviteleri ile ilgili bağımsızlık düzeyi Fonksiyonel
Bağımsızlık Ölçeği, aktivite kısıtlaması ACTIVLIM Ölçeği kulanılarak değerlendirildi.
Değerlendirmeler, çalışmanın başında ve 15 gün sonra olmak üzere iki kez
yapıldı. İstatistiksel analiz Rasch yöntemi kullanılarak yapıldı.

Sonuçlar: Çalışmaya, ortanca yaşı 10
olan 95 çocuk ve ortanca yaşı 34,5 olan 74 yetişkin dahil edildi. Yetmiş hasta
(% 41,7) ikinci kez değerlendirildi. 22 maddeden ile başlanmış olup, bir maddeye
(ACTIVLIM 5- Tuvalette oturma) ilişkin eşik değerleri, ölçek kategorileri ile
uyumsuzluk gösterecek şekilde sıra takip etmedi. Test / tekrar test
güvenirliğine göre, maddelerden hiçbiri madde işlev farklılığı göstermedi.
Ölçeğin iç tutarlılığı yeterlidir (Cronbach’ın alfa 0,94). Ölçek, dış yapı
geçerliliğini oluşturan FBÖ puanları ile beklenen korelasyonu göstermiştir
(Pearson 0,95).

Tartışma: ACTIVLIM, Türk NMH
popülasyonunda aktivite kısıtlılıklarını değerlendirmek için kullanılabilecek
güvenilir ve geçerli bir anket olarak bulunmuştur.

Anahtar Kelimeler

Nöromüsküler Hastalık, Güvenirlik ve Geçerlik, Günlük Yaşam Aktiviteleri

Kaynakça

• Andrich, D. (1988). Rasch models for measurement. London: SAGE Publications
• Andrich, D., Sheridan, B., & Luo, G. (2004). RUMM 2020: A Windows program for analysing item response data according to Rasch Unidimensional Measurement Models. Perth, Western Australia: RUMM Laboratory.
• Aybay, C., Erkin, G., Elhan, A. H., Sirzai, H., & Ozel, S. (2007). ADL assessment of nondisabled Turkish children with the WeeFIM instrument. Am J Phys Med Rehabil, 86(3), 176-182.
• Beaton, D. E., Bombardier, C., Guillemin, F., & Ferraz, M. B. (2000). Guidelines for the process of cross-cultural adaptation of self-report measures. Spine, 25(24), 3186-3191.
• Bérard, C., Payan, C., Hodgkinson, I., Fermanian, J., & MFM Collaborative Study Group. (2005). A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromusc Disord, 15(7), 463-470.
• Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297-334.
• Cup, E. H., Pieterse, A. J., ten Broek Pastoor J.M., Munneke, M., van Engelen, B. G., Hendricks, H. T., et al. (2007). Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: A systematic review. Arch Phys Med Rehabil, 88(11), 1452-1464.
• Custers, J. W., Hoijtink, H., van der Net, J., & Helders, P. J. (2000). Cultural differences in functional status measurement: analyses of person fit according to the Rasch model. Quality of Life Res, 9(5), 571-578.
• Elhan, A. H., Öztuna, D., Kutlay, Ş., Küçükdeveci, A. A., & Tennant, A. (2008). An initial application of computerized adaptive testing (CAT) for measuring disability in patients with low back pain. BMC Musculoskelet Disord, 9(1), 166.
• Emery, M. P., Perrier, L. L., & Acquadro, C. (2005). Patient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questions. Health Qual Life Out, 3(1), 12.
• Fisher, W. P. (1992). Reliability statistics. Rasch Measurement Transactions, 6(3), 238.
• Fisher, W. P. (1993). Measurement-related problems in functional assessment. The Am J Occup Ther, 47(4), 331-338.
• Hermans, M. C., Faber, C. G., De Baets, M. H., de Die-Smulders, C. E., & Merkies, I. S. (2010). Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ). Neuromusc Disord, 20(5), 310-318.
• Hobart, J. C., Cano, S. J., & Thompson, A. J. (2010). Effect sizes can be misleading: is it time to change the way we measure change?. J Neurol Neurosurg Psychiatry, 81(9), 1044-1048.
• Jensen, M. P., Abresch, R. T., & Carter, G. T. (2005). The reliability and validity of a self-report version of the FIM instrument in persons with neuromuscular disease and chronic pain. Arch Phys Med Rehabil, 86(1), 116-122.
• Küçükdeveci, A. A., Yavuzer, G., Elhan, A. H., Sonel, B., & Tennant, A. (2001). Adaptation of the Functional Independence Measure for use in Turkey. Clin Rehabil, 15(3), 311-319.
• Mayhew, A., Cano, S., Scott, E., Eagle, M., Bushby, K., Muntoni, F., et al. (2011). Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neur, 53(6), 535-542.
• Merkies, I. S. J., & Hughes, R. A. C. (2010). The measurement of disease. J Neurol Neurosurg Psychiatry, 81(9), 943-943.
• Nair, K. S., Vasanth, A., Gourie-Devi, M., Taly, A. B., Rao, S., Gayathri, N., et al. (2001). Disabilities in children with Duchenne muscular dystrophy: a profile. J Rehabil Med, 33(4), 147-149.
• Öksuz, Ç., Akel, B.S., & Bumin, G. (2011). Effect of occupational therapy on activity level and occupational peformance in patients with neuromuscular disease. Fizyotrapi Rehabil, 22(3), 231-239.
• Raggi, A., & Leonardi, M. (2009). Assessing activity limitations in patients with neuromuscular diseases: is the ACTIVLIM questionnaire linked to ICF and ICF-CY? Int J Reh Research, 32(2), 148-153.. 2009;32(2):148-53.
• Tennant, A., & Conaghan, P. G. (2007). The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Care & Res, 57(8), 1358-1362.
• Tennant, A., Penta, M., Tesio, L., Grimby, G., Thonnard, J. L., Slade, A., et al. (2004). Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project. Medical Care, 42(1), I37-I48.
• Torres, C., Moxley, R. T., & Griggs, R. C. (1983). Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy. J Neur Sci, 60(1), 157-168. Vandervelde, L., Van den Bergh, P. Y., Goemans, N., & Thonnard, J. L. (2007). ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders. Neuromusc Disord, 17(6), 459-469.
• Vandervelde, L., Van den Bergh, P. Y., Renders, A., Goemans, N., & Thonnard, J. L. (2009). Relationships between motor impairments and activity limitations in patients with neuromuscular disorders. J Neurol Neurosurg Psychiatry, 80(3), 326-332.
• Ware, J. E., Keller, S. D., Gandek, B., Brazier, J. E., Sullivan, M., & IQOLA Project Group. (1995). Evaluating translations of health status questionnaires: Methods from the IQOLA Project. International Journal of Technological Assess Health Care, 11(3), 525-551.
• World Health Organization. (2001). International classification of functioning, disability and health: ICF. Geneva: World Health Organization.